Severe Varicella Associated With Steroid Use
The DOI matches its Crossref record.
Abstract
Objective. To evaluate whether corticosteroid use is associated with severe varicella. Design. The odds of corticosteroid exposure were compared among 35 children with severe varicella and 10 000 control subjects. Results. Five (26.3%) of 19 case patients without known immunosuppression had received steroids within 30 days prior to the onset of their rash compared with 20 of the 10 000 control subjects (0.2%), giving an odds ratio of 178 (95% confidence interval 59 to 541). If 16 case patients with leukemia or other known immunosuppressive conditions were included, the odds ratio was larger (odds ratio 420, 95% confidence interval 189 to 935). Of the 13 case patients whose dosage was recorded, 7 received less than the equivalent of 2 mg/kg per day of prednisone. The timing of the steroid use in those who had severe varicella clustered within the incubation period for the virus. Conclusions. Systemic corticosteroid use appears to increase substantially the risk of severe or fatal varicella. The timing of corticosteroid exposure, in addition to dose and duration, may be an important factor in determining vulnerability. Further studies are needed to determine whether short-course, low-dose, or inhaled steroids are associated with similarly increased risk. Physicians should be aware that varicella-susceptible patients receiving corticosteroids are at considerably increased risk for severe varicella and should consider how to counsel their patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547262006-001 · Cited by 1,079
Styczynski, J., Reusser, P., Einsele, H., de la Camara, R., Cordonnier, C., Ward, K. N., Ljungman, P., Engelhard, D., & Leukemia, F. T. E. C. O. I. I. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.386 · Cited by 380
Management of Childhood Onset Nephrotic Syndrome
Gipson, D. S., Massengill, S. F., Yao, L., Nagaraj, S., Smoyer, W. E., Mahan, J. D., Wigfall, D., Miles, P., Powell, L., Lin, J.-J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-1559 · Cited by 314
Trautmann, A., Boyer, O., Hodson, E., Bagga, A., Gipson, D. S., Samuel, S., Wetzels, J., Alhasan, K., Banerjee, S., Bhimma, R., et al. (2023) · Pediatric Nephrology · doi:10.1007/s00467-022-05739-3 · Cited by 292
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Sarnes, E., Crofford, L., Watson, M., Dennis, G., Kan, H., & Bass, D. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.009 · Cited by 258
Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention
Fardet, L., Kassar, A., Cabane, J., & Flahault, A. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00005 · Cited by 254
Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children
Aljebab, F., Choonara, I., & Conroy, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170259 · Cited by 172
Mikaeloff, Y., Kezouh, A., & Suissa, S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02997.x · Cited by 132
Metadata
- Authors
- Dowell, S. F., & Bresee, J. S.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1993-08-01
- Volume
- 92
- Issue
- 2
- Pages
- 223-228
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1591786310
- Cited by
- 148
- References
- 0
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.